Barfresh Food Group Inc. — FY2019 Form 10-K Summary
Business context and reporting period
Barfresh develops, manufactures through U.S. contract manufacturers, and distributes ready-to-blend frozen beverages, including smoothies, shakes, and frappes. Products are sold in single-serve portion packs and bulk “Easy Pour” containers through national accounts, regional accounts, distributors, schools, military bases, and foodservice channels.
The filing covers the fiscal year ended December 31, 2019, with comparative results for 2018. Although the request identifies “2019 Q4,” this is an annual Form 10-K rather than a quarterly filing. The company is a smaller reporting company whose common stock trades on the OTCQB under “BRFH.”
Financial performance and condition
| Metric | 2019 | 2018 | Change |
|---|---|---|---|
| Revenue | $4.307 million | $4.235 million | Up 2% |
| Gross profit | $2.313 million | $2.145 million | Up $169 thousand |
| Gross margin | 54% | 51% | Improved |
| Operating loss | $5.187 million | $6.180 million | Improved 16% |
| Net loss | $5.593 million | $7.323 million | Improved 24% |
| Basic and diluted loss per share | $0.04 loss | $0.06 loss | Improved |
| Cash used in operating activities | $3.353 million | $4.128 million | Improved |
Cost of revenue declined to $1.928 million from $2.033 million, primarily reflecting production scale and product mix. General and administrative expense declined 12% to $6.851 million, driven by lower personnel, stock compensation, legal, marketing, travel, rent, research and development, and shipping costs. Research and development expense declined to $538 thousand from $674 thousand.
At December 31, 2019, cash was $1.000 million and restricted cash was $91 thousand. Working capital surplus was $146 thousand, down from $652 thousand at December 31, 2018. Total assets were $5.126 million and total liabilities were $4.842 million. Stockholders’ equity was $284 thousand, compared with a $35 thousand deficit in 2018.
The company used $466 thousand for equipment purchases and $5 thousand for patents and trademarks. Financing activities provided $3.875 million, including $1.500 million from warrant exercises and $2.400 million from stock issuance. The company had $2.740 million of net outstanding Series CN convertible notes at year-end, plus derivative liabilities of $211 thousand. Convertible notes bear 10% interest in the principal arrangements described in the filing, with variable conversion provisions and associated warrants.
Material changes versus the prior comparable period
- Revenue increased modestly by 2%, while gross margin improved from 51% to 54%.
- Operating loss narrowed by approximately $993 thousand, primarily from higher gross profit and lower operating expenses.
- Net loss narrowed by approximately $1.730 million. Results included $1.213 million of interest expense, $307 thousand of warrant modification expense, and a $1.115 million gain from the change in fair value of derivative liabilities.
- Cash used in operations improved by approximately $775 thousand, but remained substantially negative.
- Inventory declined from $1.226 million to $635 thousand, while the inventory reserve increased from $31 thousand to $101 thousand.
- Headcount declined from 26 full-time employees at year-end 2018 to 17 at the end of 2019. The reduction contributed to lower expenses but also led to an identified internal-control weakness.
- The exclusive Sysco distribution agreement expired on October 2, 2019, allowing the company to pursue additional distributors outside the Sysco network.
Guidance, outlook, commentary, risks, and unusual items
Management expected 2020 gross margin to be comparable to 2019 and anticipated continued reductions in shipping and storage costs as distribution became more efficient. The filing does not provide formal revenue or earnings guidance.
Management stated that the company has a history of operating losses and negative operating cash flow and may need additional equity or debt financing. The filing states that these conditions raised substantial doubt about the company’s ability to meet obligations for the twelve months following filing. Management concluded that expense reductions, a $3.825 million private placement completed on March 23, 2020, and debt extensions and conversions alleviated the substantial doubt; however, management acknowledged that financing and liquidity outcomes remain uncertain.
Subsequent to year-end, the company issued 7.650 million shares for $3.825 million of proceeds, subject to potential price adjustments and warrant issuance. It also converted or extended portions of its Milestone I and Milestone II convertible notes. These transactions may reduce near-term cash obligations but create potential equity dilution and additional warrant exposure.
COVID-19 began affecting operations near the end of the first quarter of 2020. Restaurant closures and furloughs reduced demand for single-serve products, while school closures threatened bulk-product sales. The company reported no supply-chain disruption as of the filing date, but stated that the duration and magnitude of the effects were uncertain.
Other material risks include customer concentration, reliance on contract manufacturers and distributors, variable order volumes without minimum purchase commitments, ingredient and packaging cost inflation, inventory spoilage, competition, product liability, intellectual-property risks, OTCQB trading illiquidity, potential dilution, and the need to retain key personnel.
Management and the principal financial officer concluded that disclosure controls and internal control over financial reporting were ineffective as of December 31, 2019 because of inadequate segregation of duties following headcount reductions. Management planned to add financial personnel, but provided no assurance regarding the timing or success of remediation.
Most important facts for investors to verify
- Whether revenue growth can accelerate sufficiently to overcome annual operating losses of more than $5 million and recurring negative operating cash flow.
- Available cash after the March 2020 financing, debt conversions, and COVID-19-related effects, including the company’s ability to meet remaining note maturities and lease obligations.
- The final terms, dilution potential, and price-adjustment mechanics of the March 2020 private placement and related O warrants.
- Progress in remediating the material weakness in segregation of duties and whether additional control deficiencies are identified.
- The effect of the expired Sysco exclusivity arrangement on distribution growth, customer concentration, and margins.
- The sustainability of the 54% gross margin and the company’s ability to control shipping, ingredient, packaging, manufacturing, and inventory costs.
- The impact of COVID-19 on restaurant, school, and military sales and whether contract-manufacturing capacity remains sufficient.
- The terms, conversion status, and remaining balances of the company’s convertible notes, warrants, and derivative liabilities.